Antimicrobial Resistance in UTIs – Exploring the Science of Cranberry

In this concise clinical and evidence-based review, Dr Howell will:

Discover the prevalence and recurrence statistics of UTIs globally and in Australia
Review the current medical management of UTIs
Understand insights into the development of antimicrobial resistance (AMR)
Learn about the unusual PAC types and their metabolites in cranberry
Examine the mechanisms of action for cranberry in UTIs

Find out how cranberry affects E.coli adherence to bladder cells
Discover the potential use of cranberry in UTI recurrence and AMR reduction
Review the scientific evidence for cranberry in UTIs for adults and children
Understand dosages and advantages of supplemental cranberry

More health professional resources

UTIs and antimicrobial resistance - An infographic and statistical review

This educational infographic provides a statistical review of the prevalence of UTIs in Australia and their economic impact in relation to antimicrobial resistance (AMR).

The therapeutic workings of cranberry in the urinary tract and beyond

Cranberry can reduce reoccurring medically diagnosed cystitis without causing antimicrobial resistance. But how does it work in the urinary tract and does its activity extend to the digestive system?

Cranberry and PACs for recurrent cystitis in adults and children

Cystitis is the most common type of urinary tract infection affecting over 50% of women. Cranberry, with 36mg PACs, has been clinically researched for recurrent cystitis in children and adults.

Antimicrobial Resistance in UTIs – the Science of Cranberry